Citi Downgrades PTC Therapeutics (PTCT) to Sell, 'Regulatory Headwinds Compound'
Tweet Send to a Friend
(Updated - October 27, 2023 6:01 AM EDT)
Citi analyst David Lebowitz downgraded PTC Therapeutics (NASDAQ: PTCT) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi analyst David Lebowitz downgraded PTC Therapeutics (NASDAQ: PTCT) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
